These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2898045)

  • 1. Effect of intranasal glucagon on blood glucose levels in healthy subjects and hypoglycaemic patients with insulin-dependent diabetes.
    Freychet L; Rizkalla SW; Desplanque N; Basdevant A; Zirinis P; Tchobroutsky G; Slama G
    Lancet; 1988 Jun; 1(8599):1364-6. PubMed ID: 2898045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new non-invasive method for treating insulin-reaction: intranasal lyophylized glucagon.
    Slama G; Alamowitch C; Desplanque N; Letanoux M; Zirinis P
    Diabetologia; 1990 Nov; 33(11):671-4. PubMed ID: 2076798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal glucagon treatment relieves hypoglycaemia in children with type 1 (insulin-dependent) diabetes mellitus.
    Stenninger E; Aman J
    Diabetologia; 1993 Oct; 36(10):931-5. PubMed ID: 8243872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal glucagon as remedy for hypoglycemia. Studies in healthy subjects and type I diabetic patients.
    Pontiroli AE; Calderara A; Pajetta E; Alberetto M; Pozza G
    Diabetes Care; 1989 Oct; 12(9):604-8. PubMed ID: 2676430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal glucagon in the treatment of hypoglycaemic attacks in children: experience at a summer camp.
    Slama G; Reach G; Cahane M; Quetin C; Villanove-Robin F
    Diabetologia; 1992 Apr; 35(4):398. PubMed ID: 1516770
    [No Abstract]   [Full Text] [Related]  

  • 6. Nasal glucagon in the treatment of hypoglycaemia in type 1 (insulin-dependent) diabetic patients.
    Rosenfalck AM; Bendtson I; Jørgensen S; Binder C
    Diabetes Res Clin Pract; 1992 Jul; 17(1):43-50. PubMed ID: 1511660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?
    Pontiroli AE; Ceriani V
    Diabetes Obes Metab; 2018 Aug; 20(8):1812-1816. PubMed ID: 29652110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Glucagon for Severe Hypoglycemia.
    Grant JS; Graven LJ
    Home Healthc Now; 2017 Feb; 35(2):114-115. PubMed ID: 28157777
    [No Abstract]   [Full Text] [Related]  

  • 9. Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study.
    Rickels MR; Ruedy KJ; Foster NC; Piché CA; Dulude H; Sherr JL; Tamborlane WV; Bethin KE; DiMeglio LA; Wadwa RP; Ahmann AJ; Haller MJ; Nathan BM; Marcovina SM; Rampakakis E; Meng L; Beck RW;
    Diabetes Care; 2016 Feb; 39(2):264-70. PubMed ID: 26681725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon Nasal Powder: A Promising Alternative to Intramuscular Glucagon in Youth With Type 1 Diabetes.
    Sherr JL; Ruedy KJ; Foster NC; Piché CA; Dulude H; Rickels MR; Tamborlane WV; Bethin KE; DiMeglio LA; Fox LA; Wadwa RP; Schatz DA; Nathan BM; Marcovina SM; Rampakakis E; Meng L; Beck RW;
    Diabetes Care; 2016 Apr; 39(4):555-62. PubMed ID: 26884472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal glucagon: a promising approach for treatment of severe hypoglycemia.
    Pontiroli AE
    J Diabetes Sci Technol; 2015 Jan; 9(1):38-43. PubMed ID: 25385946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes.
    Rickels MR; DuBose SN; Toschi E; Beck RW; Verdejo AS; Wolpert H; Cummins MJ; Newswanger B; Riddell MC;
    Diabetes Care; 2018 Sep; 41(9):1909-1916. PubMed ID: 29776987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterregulatory hormones in insulin-treated diabetic patients admitted to an accident and emergency department with hypoglycaemia.
    Hvidberg A; Christensen NJ; Hilsted J
    Diabet Med; 1998 Mar; 15(3):199-204. PubMed ID: 9545120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mini-dose glucagon rescue for hypoglycemia in children with type 1 diabetes.
    Haymond MW; Schreiner B
    Diabetes Care; 2001 Apr; 24(4):643-5. PubMed ID: 11315823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose recovery after intranasal glucagon during hypoglycaemia in man.
    Hvidberg A; Djurup R; Hilsted J
    Eur J Clin Pharmacol; 1994; 46(1):15-7. PubMed ID: 7911762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Use of Intranasal Glucagon: Resolution of Hypoglycemia.
    Pontiroli AE; Tagliabue E
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31349701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intranasal glucagon in the treatment of hypoglycemia. A therapeutic possibility in the future].
    Carstens S; Andersen I
    Ugeskr Laeger; 1994 Jul; 156(30):4339-42. PubMed ID: 8066934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal versus injectable glucagon for hypoglycemia in type 1 diabetes: systematic review and meta-analysis.
    Pontiroli AE; Tagliabue E
    Acta Diabetol; 2020 Jun; 57(6):743-749. PubMed ID: 32025860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia.
    Porcellati F; Pampanelli S; Rossetti P; Busciantella Ricci N; Marzotti S; Lucidi P; Santeusanio F; Bolli GB; Fanelli CG
    Diabetologia; 2007 Feb; 50(2):422-30. PubMed ID: 17160672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Usability of Intranasal Glucagon for the Management of Hypoglycemia in Patients With Diabetes: A Systematic Review.
    Singh-Franco D; Moreau C; Levin AD; Rosa D; Johnson M
    Clin Ther; 2020 Sep; 42(9):e177-e208. PubMed ID: 32873417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.